首站-论文投稿智能助手
典型文献
Spontaneous xenogeneic GvHD in Wilms ' tumor Patient- Derived xenograft models and potential solutions
文献摘要:
Severely immunocompromised NOD.Cg- Prkdc scid Il2rg tm1Sug (NOG) mice are among the ideal animal recipients for generation of human cancer models. Transplantation of human solid tumors having abundant tumor-i nfiltrating lymphocytes (TILs) can induce xenogeneic graft- versus- host disease (xGvHD) following engraftment and expansion of the TILs inside the animal body. Wilms' tumor (WT) has not been recognized as a lymphocyte- predominant tumor. However, 3 consecutive generations of NOG mice bearing WT patient- derived xenografts (PDX) xenotransplanted from a single donor showed different degrees of inflammatory symptoms after transplantation before any therapeutic intervention. In the initial generation, dermatitis, auto- amputation of digits, weight loss, lymphadenopathy, hepatitis, and interstitial pneumonitis were observed. Despite antibiotic treatment, no response was noticed, and thus the ani-mals were prematurely euthanized (day 47 posttransplantation). Laboratory and his-topathologic evaluations revealed lymphoid infiltrates positively immunostained with anti- human CD3 and CD8 antibodies in the xenografts and primary tumor, whereas no microbial infection or lymphoproliferative disorder was found. Mice of the next generation that lived longer (91 days) developed sclerotic skin changes and more severe pneumonitis. Cutaneous symptoms were milder in the last generation. The xenografts of the last 2 generations also contained TILs, and lacked lymphoprolifera-tive transformation. The systemic immunoinflammatory syndrome in the absence of microbial infection and posttransplant lymphoproliferative disorder was suggestive of xGvHD. While there are few reports of xGvHD in severely immunodeficient mice xenotransplanted from lymphodominant tumor xenografts, this report for the first time documented serial xGvHD in consecutive passages of WT PDX- bearing models and discussed potential solutions to prevent such an undesired complication.
文献关键词:
作者姓名:
Seyed Mostafa Monzavi;Ahad Muhammadnejad;Maryam Behfar;Amir Arsalan Khorsand;Samad Muhammadnejad;Abdol-Mohammad Kajbafzadeh
作者机构:
Department of Applied Cell Sciences,School of Advanced Technologies in Medicine,Tehran University of Medical Sciences,Tehran,Iran;Pediatric Urology and Regenerative Medicine Research Center,Tehran University of Medical Sciences,Tehran,Iran;Gene Therapy Research Center,Digestive Diseases Research Institute,Tehran University of Medical Sciences,Tehran,Iran;Cancer Biology Research Center,Cancer Institute of Iran,Tehran University of Medical Sciences,Tehran,Iran;PDX Platform,Biomarker Evaluation and Supervision Team for Personalized Medicine,Molecular Tumor Board,Cancer Institute of Iran,Tehran University of Medical Sciences,Tehran,Iran;Pediatric Cell and Gene Therapy Research Center,Tehran University of Medical Sciences,Tehran,Iran
引用格式:
[1]Seyed Mostafa Monzavi;Ahad Muhammadnejad;Maryam Behfar;Amir Arsalan Khorsand;Samad Muhammadnejad;Abdol-Mohammad Kajbafzadeh-.Spontaneous xenogeneic GvHD in Wilms ' tumor Patient- Derived xenograft models and potential solutions)[J].动物模型与实验医学(英文),2022(04):389-396
A类:
Prkdc,scid,Il2rg,tm1Sug,nfiltrating,xGvHD,xenotransplanted,topathologic,immunostained,sclerotic,lymphoprolifera,immunoinflammatory,lymphodominant
B类:
Spontaneous,xenogeneic,Wilms,Patient,Derived,models,potential,solutions,Severely,immunocompromised,NOD,Cg,NOG,mice,are,among,ideal,animal,recipients,human,cancer,Transplantation,solid,tumors,having,abundant,lymphocytes,TILs,induce,versus,host,disease,following,engraftment,expansion,inside,body,WT,has,been,recognized,predominant,However,consecutive,generations,bearing,patient,derived,xenografts,PDX,from,single,donor,showed,different,degrees,symptoms,after,before,any,therapeutic,intervention,In,initial,dermatitis,auto,amputation,digits,weight,loss,lymphadenopathy,hepatitis,interstitial,pneumonitis,were,observed,Despite,antibiotic,treatment,response,was,noticed,thus,mals,prematurely,euthanized,posttransplantation,Laboratory,evaluations,revealed,lymphoid,infiltrates,positively,CD3,CD8,antibodies,primary,whereas,microbial,infection,lymphoproliferative,disorder,found,Mice,next,that,lived,longer,days,developed,skin,changes,more,Cutaneous,milder,last,also,contained,lacked,transformation,systemic,syndrome,absence,suggestive,While,there,few,reports,severely,immunodeficient,this,first,documented,serial,passages,discussed,prevent,such,undesired,complication
AB值:
0.555634
相似文献
Spirulina platensis aqueous extracts ameliorate colonic mucosal damage and modulate gut microbiota disorder in mice with ulcerative colitis by inhibiting inflammation and oxidative stress
Jian WANG;Liqian SU;Lun ZHANG;Jiali ZENG;Qingru CHEN;Rui DENG;Ziyan WANG;Weidong KUANG;Xiaobao JIN;Shuiqing GUI;Yinghua XU;Xuemei LU-Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances,School of Life Science and Biopharmaceutics,Guangdong Pharmaceutical University,Guangzhou 510006,China;School of Pharmacy,Guangdong Pharmaceutical University,Guangzhou 510006,China;Intensive Care Unit,Shenzhen Second People's Hospital,the First Affiliated Hospital of Shenzhen University,Shenzhen 518031,China;Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products,National Institutes for Food and Drug Control,Beijing 102629,China
Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells
Leyi Yao;Qian Zhao;Ding Yan;Ziying Lei;Yali Hao;Jinghong Chen;Qian Xue;Xiaofen Li;Qingtian Huang;Daolin Tang;Q.Ping Dou;Xin Chen;Jinbao Liu-Affiliated Cancer Hospital&Institute of Guangzhou Medical University,Guangzhou 510095,China;Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation,State Key Laboratory of Respiratory Disease,School of Basic Medical Sciences,Guangzhou Medical University,Guangzhou 511436,China;Institute of Digestive Disease of Guangzhou Medical University,The Sixth Affiliated Hospital of Guangzhou Medical University,Qingyuan People's Hospital,Qingyuan 511518,China;School of Public Health,Guangzhou Medical University,Guangzhou,511436,China;Department of Surgery,UT Southwestern Medical Center,Dallas,TX 75390,USA;Barbara Ann Karmanos Cancer Institute and Departments of Oncology,Pharmacology&Pathology,School of Medicine,Wayne State University,Detroit,MI 48201,USA
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
Chalcone derivatives ameliorate lipopolysaccharide-induced acute lung injury and inflammation by targeting MD2
Ya-li Zhang;Wen-xin Zhang;Jue-qian Yan;Ye-lin Tang;Wen-jing Jia;Zheng-wei Xu;Ming-jiang Xu;Nipon Chattipakorn;Yi Wang;Jian-peng Feng;Zhi-guo Liu;Guang Liang-Chemical Biology Research Center,School of Pharmaceutical Sciences,Wenzhou Medical University,Wenzhou 325035,China;Key Laboratory of Molecular Pharmacology and Drug Evaluation(Yantai University),Ministry of Education,Yantai University,Yantai 264005,China;School of Pharmaceutical Sciences,Hangzhou Medical College,Hangzhou 311399,China;Zhuji Biomedicine Institute,School of Pharmaceutical Sciences,Wenzhou Medical University,Zhuji 311800,China;Cardiac Electrophysiology Research and Training Center,Faculty of Medicine,Chiang Mai University,Chiang Mai 50200,Thailand;Wenzhou Institute,University of Chinese Academy of Sciences,Wenzhou 325001,China
Pharmacodynamic,pharmacokinetic,and phase 1a study of bisthianostat,a novel histone deacetylase inhibitor,for the treatment of relapsed or refractory multiple myeloma
Yu-bo Zhou;Yang-ming Zhang;Hong-hui Huang;Li-jing Shen;Xiao-feng Han;Xiao-bei Hu;Song-da Yu;An-hui Gao;Li Sheng;Ming-bo Su;Xiao-li Wei;Yue Zhang;Yi-fan Zhang;Zhi-wei Gao;Xiao-yan Chen;Fa-jun Nan;Jia Li;Jian Hou-National Center for New Drug Screening,State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China;Yantai Key Laboratory of Nanomedicine&Advanced Preparations,Yantai Institute of Materia Medica,Yantai 264000,China;Department of Hematology,Renji Hospital,Shanghai Jiaotong University School of Medicine,Shanghai 200127,China;Shanghai Center for Drug Metabolism and Pharmacokinetics Research,Shanghai 201203,China
Pharmacological characterization of a novel metal-based proteasome inhibitor Na-AuPT for cancer treatment
Da-cai Xu;Li Yang;Pei-quan Zhang;Ding Yan;Qian Xue;Qing-tian Huang;Xiao-fen Li;Ya-li Hao;Dao-lin Tang;Q.Ping Dou;Xin Chen;Jin-bao Liu-Affliated Cancer Hospital&Institute of Guangzhou Medical University,Guangzhou 510095,China;Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation,School of Basic Medical Sciences,Guangzhou Medical University,Guangzhou 511436,China;The Department of Physiology,School of Basic Medical Sciences,Guizhou Medical University,Guiyang 550003,China;Department of Surgery,UT Southwestern Medical Center,Dallas,TX 75390,USA;Barbara Ann Karmanos Cancer Institute and Departments of Oncology,Pharmacology&Pathology,School of Medicine,Wayne State University,Detroit,MI 48201,USA
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。